USD10
VSTM Shares
About VerastemVerastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
USD10
VSTM Shares
About VerastemVerastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$365.55M
OPEN PRICE
$4.24
LOW (1Y)
$3.55
HIGH (1Y)
$11.25
LOW (24H)
$4.11
HIGH (24H)
$4.43
VOLUME (24H)
$4.77M
88.89%
Price history
Time | Price | Change |
|---|---|---|
Today | $4.24 | |
1 Day | $4.12 | |
1 Week | $4.12 | |
1 Month | $4.22 | |
1 Year | $4.62 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.